| Quarter | Score |
|---|---|
| 2022-Q1 | 49.4 |
| 2022-Q3 | 65.5 |
| 2022-Q4 | 49.9 |
| 2023-Q2 | 41.6 |
| 2023-Q3 | 50.1 |
| 2023-Q4 | 36.0 |
| 2024-Q1 | 34.7 |
| 2024-Q2 | 51.7 |
| 2024-Q3 | 79.3 |
| 2024-Q4 | 75.6 |
| 2025-Q1 | 75.8 |
| 2025-Q2 | 75.8 |
| 2025-Q3 | 76.1 |
| 2025-Q4 | 75.7 |
| 2026-Q1 | 76.1 |
| 2026-Q2 | 76.7 |
Strong consensus, but price is extended — wait for pullback to funds' basis
Trading +103.7% above funds' purchase price — elevated pullback risk
2 of 18 tracked funds hold SIRI. Avg conviction: 0.6%. Net adding. First tracked at $13.24 (current +103.7% vs tracked).
Berkshire Hathaway has 1.2% in this stock
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 17 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Berkshire Hathaway | 1.2% | Hold |
| Citadel Advisors | 0.0% | Add |